Sponsored

The Analysis of Fairmount Funds Management LLC's Holdings

Currently, Fairmount Funds Management LLC holds 16 types of securities in its portfolio with a total value $2.7B. In the most recent quarter, they have increased their positions in APGE (+8.7M shares, valued at $681.5M), APGE (+3.9M shares, valued at $294.4M), COGT (+7.3M shares, valued at $257.8M); decreased their positions in N/A (-2.9M shares, valued at $34.3M); initiated new positions in GLTO (+8.7M shares, valued at $189.9M), SYRE (+4.0M shares, valued at $131.6M), VRDN (+3.9M shares, valued at $121.8M).

Top Holding Treemap

Sponsored

Stock Holdings

TickerCompany NameSharesShares △%Event DateReport DateHistory

COGT COGENT BIOSCIENCES INC16.3M shares80.62%2026-01-222026-01-22

APGE 15.4M shares130.37%2026-03-312026-03-31

APGE APOGEE THERAPEUTICS INC5.9M shares190.36%2026-01-222026-01-22

GLTO 8.7M sharesnew addition2026-02-092026-02-11

SYRE SPYRE THERAPEUTICS INC4.0M sharesnew addition2025-12-312026-02-17

VRDN VIRIDIAN THERAPEUTICS INC3.9M sharesnew addition2025-12-312026-02-17

ORKA ORUKA THERAPEUTICS INC3.7M sharesnew addition2025-12-312026-02-17

DNTH DIANTHUS THERAPEUTICS INC2.1M sharesnew addition2025-12-312026-02-17

Sponsored

ZBIO ZENAS BIOPHARMA INC2.2M sharesnew addition2025-12-312026-02-17

NUVL NUVALENT INC727.6K sharesnew addition2025-12-312026-02-17

JBIO JADE BIOSCIENCES INC4.6M sharesnew addition2025-12-312026-02-17

ELVN ENLIVEN THERAPEUTICS INC3.7M sharesnew addition2025-12-312026-02-17

KINIKSA PHARMACEUTICALS INTL KINIKSA PHARMACEUTICALS INTL1.3M sharesnew addition2025-12-312026-02-17

CRESCENT BIOPHARMA INC. CRESCENT BIOPHARMA INC.2.7M shares-51.31%2025-12-312026-02-17

IKT 12.5M sharesnew addition2025-12-312026-02-17

INHIBIKASE THERAPEUTICS INC INHIBIKASE THERAPEUTICS INC8.6M sharesnew addition2025-12-312026-02-17

Sponsored

Call Option Holdings

No call option holdings data available

Put Option Holdings

No put option holdings data available